Comparison of genotype distributions between MI patients and healthy control subjects
| . | Males (%) . | Females (%) . | OR (95% CI) . | P . |
|---|---|---|---|---|
| FII 20210A | ||||
| MI | 8 of 221 (3.6) | 8 of 279 (2.9) | 1.3 (0.5, 3.5) | .635 |
| HC | 3 of 214 (1.4) | 2 of 286 (0.7) | 2.0 (0.3, 12.2) | .435 |
| FVL | ||||
| MI | 16 of 221 (7.2) | 7 of 279 (2.5) | 3.0 (1.2, 7.5) | .012 |
| HC | 8 of 214 (3.7) | 15 of 286 (5.2) | 0.7 (0.3, 1.7) | .426 |
| FXIII-A Leu34 | ||||
| MI | 140 of 221 (63.3) | 95 of 279 (34.1) | 3.3 (2.3, 4.8) | <.001 |
| HC | 97 of 214 (45.3) | 110 of 286 (38.5) | 1.3 (0.9, 1.9) | .123 |
| . | Males (%) . | Females (%) . | OR (95% CI) . | P . |
|---|---|---|---|---|
| FII 20210A | ||||
| MI | 8 of 221 (3.6) | 8 of 279 (2.9) | 1.3 (0.5, 3.5) | .635 |
| HC | 3 of 214 (1.4) | 2 of 286 (0.7) | 2.0 (0.3, 12.2) | .435 |
| FVL | ||||
| MI | 16 of 221 (7.2) | 7 of 279 (2.5) | 3.0 (1.2, 7.5) | .012 |
| HC | 8 of 214 (3.7) | 15 of 286 (5.2) | 0.7 (0.3, 1.7) | .426 |
| FXIII-A Leu34 | ||||
| MI | 140 of 221 (63.3) | 95 of 279 (34.1) | 3.3 (2.3, 4.8) | <.001 |
| HC | 97 of 214 (45.3) | 110 of 286 (38.5) | 1.3 (0.9, 1.9) | .123 |